Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
0.7001
-0.2999 (-29.99%)
At close: Oct 20, 2026
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $1.87 million as of October 20, 2026. It is the 48,168th most valuable company in the world and the 6,473rd biggest in the United States. Its market cap has increased by 47.36% in one year.
Market Cap
1.87M
Enterprise Value
n/a
Revenue
601.00K
Global Rank
Country Rank
#6,473 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 1.87M, a decrease of -98.56%. That is a compound annual growth rate of -40.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 1.87M | -34.90% |
| Dec 31, 2025 | 2.88M | 9.74% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Affymax | 3.10M |
| Bioxytran | 2.57M |
| GPL Holdings | 2.56M |
| Pacific Software | 2.50M |
| Enzolytics | 2.42M |
| Mosaic ImmunoEngineering | 2.41M |
| Abpro Holdings | 2.41M |
| AccuStem Sciences | 2.37M |